AptarGroup Inc. (ATR) Business Metric Overview - Stocknear

AptarGroup Inc.

NYSE: ATR · Real-Time Price · USD
130.70
-0.80 (-0.61%)
At close: Sep 25, 2025, 10:05 AM

Aptar Revenue Breakdown

Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011
Beauty And Home Revenue 339.17M 359.82M 371.35M 368.2M 374.93M 374.09M 360.25M 346.95M 359.41M 337.23M 299.79M 324.56M 314.79M 328.18M 342.08M 367.66M 337.91M 227.51M 368.54M 378.17M 335.47M 333.75M 322.12M 322.45M 290.4M 316.03M 340.32M 314.34M 302.77M 321.64M 319.12M 329.41M 342.93M 378.9M 391.38M 388.7M 1.42B 344.72M 365.99M 337.79M 1.18B 312.09M 266.07M 280.4M 830.33M 136.2M
Beauty And Home Revenue Growth -5.74% -3.10% +0.85% -1.79% +0.22% +3.84% +3.83% -3.47% +6.58% +12.49% -7.63% +3.10% -4.08% -4.06% -6.96% +8.80% +48.52% -38.27% -2.55% +12.73% +0.52% +3.61% -0.10% +11.04% -8.11% -7.14% +8.27% +3.82% -5.87% +0.79% -3.12% -3.94% -9.49% -3.19% +0.69% -72.58% +311.23% -5.81% +8.35% -71.31% +277.21% +17.30% -5.11% -66.23% +509.63% n/a
Food + Beverage Revenue 121.58M 133.64M 132.97M 134.27M 131.56M 138.13M 125.44M 115.98M 319.89M 315.76M 301.26M 297.2M 267.16M 269.25M 281.94M 272.7M 255.8M 341.76M 241.21M 230.13M 207.72M 199.55M 201.7M 196.91M 176.11M 191.19M 191.03M 183.13M 174.82M 175.43M 183.3M 178.67M 182M 179.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 293.04M
Food + Beverage Revenue Growth -9.02% +0.51% -0.97% +2.06% -4.75% +10.11% +8.16% -63.75% +1.31% +4.81% +1.37% +11.24% -0.78% -4.50% +3.39% +6.61% -25.15% +41.69% +4.82% +10.79% +4.10% -1.07% +2.43% +11.81% -7.89% +0.08% +4.31% +4.75% -0.34% -4.30% +2.59% -1.83% +1.57% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pharma Revenue 335.17M 343.4M 340.23M 342.46M 345.6M 313.23M 325.34M 313.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pharma Revenue Growth -2.40% +0.93% -0.65% -0.91% +10.33% -3.72% +3.67% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Jun 30, 2025 Mar 31, 2025 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Jun 30, 2018 Mar 31, 2018
Asia Revenue 104.12M 93.69M 103.44M 92.33M 91.07M 55.98M 54.83M 52.51M 7.95M 9.11M
Asia Revenue Growth +11.14% -9.42% +12.03% +1.38% +62.70% +2.08% +4.43% +560.47% -12.74% n/a
Europe Revenue 476M 438.65M 445.13M 450.13M 474.39M 509.2M 525.08M 496.47M 183.17M 175.68M
Europe Revenue Growth +8.51% -1.46% -1.11% -5.11% -6.84% -3.02% +5.76% +171.05% +4.26% n/a
Latin America Revenue 76.14M 72.51M 69.16M 77.79M 72.08M 73.04M 71.46M 62.62M 6.82M 6.25M
Latin America Revenue Growth +5.00% +4.86% -11.10% +7.92% -1.31% +2.21% +14.12% +818.26% +9.19% n/a
North America Revenue 309.75M 282.46M 291.57M 289.82M 277.9M 254.78M 244.53M 248.48M 43.27M 39.1M
North America Revenue Growth +9.66% -3.13% +0.60% +4.29% +9.08% +4.19% -1.59% +474.20% +10.69% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 151.14M 155.28M 138.51M 141.6M 149.33M 152.78M 138.29M 138.14M 141.43M 147.92M 127.91M 135.43M 135.38M 145.54M 411.19M 135.93M 137.5M 134.35M 128.82M 121.85M 115.36M 126.19M 108.09M 111.56M 113.75M 121.22M 106.81M 103.57M 107.11M 112.46M 95.36M 95.75M 95.66M 101.52M 81.72M 86.69M 96.13M 103.02M 84.59M 81.37M 89.31M 96.19M
Selling, General, and Administrative Revenue Growth -2.66% +12.10% -2.18% -5.17% -2.26% +10.47% +0.11% -2.33% -4.39% +15.65% -5.55% +0.03% -6.98% -64.61% +202.50% -1.14% +2.35% +4.29% +5.72% +5.62% -8.58% +16.75% -3.11% -1.93% -6.16% +13.49% +3.12% -3.30% -4.76% +17.94% -0.41% +0.09% -5.77% +24.22% -5.74% -9.82% -6.68% +21.78% +3.96% -8.89% -7.15% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a 92.8M n/a n/a n/a n/a n/a n/a n/a 276.84M 135.93M 140.91M n/a 92.5M 121.85M 123.36M -292.76M 82.8M 111.56M 113.75M n/a 75.3M 103.57M 107.11M n/a 68.2M 95.75M 95.66M n/a 66.2M 86.69M 96.13M n/a 67.1M 81.37M 89.31M n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a -100.00% +103.67% -3.54% n/a -100.00% -24.09% -1.23% -142.14% -453.58% -25.78% -1.93% n/a -100.00% -27.30% -3.30% n/a -100.00% -28.77% +0.09% n/a -100.00% -23.64% -9.82% n/a -100.00% -17.54% -8.89% n/a n/a